Novo Nordisk Reports Strong 2024 Earnings Performance

Novo Nordisk sees significant profit rise in FY2024. Their earnings per share increased by 22%, indicating robust performance.

Date: 05-02-2025

AI Rating: 8

Earnings Per Share (EPS): The reported earnings per share (EPS) saw a noteworthy increase of 22%, rising to 22.63 kroner from 18.62 kroner in the previous year. This growth signifies a strong performance and investor confidence in the company's profitability.

Net Income: The net profit climbed by 21% to 100.9 billion Danish kroner compared to 83.68 billion kroner last year. This substantial increase suggests effective management and strong market conditions.

Revenue Growth: Net sales experienced a remarkable growth of 25%, reaching 290.40 billion kroner up from 232.26 billion kroner the previous year. This substantial revenue increase indicates a thriving market for Novo Nordisk's offerings.

Outlook: The company anticipates continued growth for fiscal 2025 with expected sales growth of 16-24% at constant exchange rates and operating profit growth of 19-27%. This positive outlook should encourage investor optimism.

Stocks: NVO